ARTICLE
|
doi:10.20944/preprints202209.0197.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
alpha-synuclein; SNCA; major depression; dysthymia; Parkinson’s disease; dementia; neurodegeneration; gene-environment interaction; PM2.5; pesticides
Online: 14 September 2022 (08:38:38 CEST)
REVIEW
|
doi:10.20944/preprints202007.0334.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
alpha-synuclein; SNCA; PARK2; 22q11.2 deletion syndrome; autism spectrum disorders; neuronal development; Parkinson’s disease; neurodegeneration; synaptic dysfunction
Online: 15 July 2020 (11:36:30 CEST)
ARTICLE
|
doi:10.20944/preprints202101.0149.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Apolipoprotein E (ApoE); microtubule associated protein (MAPT); synuclein alpha (SNCA); eQTL; TOMM40; KANSL1; mitochondria; Parkinson’s Progression Markers Initiative (PPMI)
Online: 8 January 2021 (11:45:19 CET)
ARTICLE
|
doi:10.20944/preprints202005.0001.v1
Subject:
Biology And Life Sciences,
Cell And Developmental Biology
Keywords:
CRISPR-Cas9; high-content screening (HCS); fluorescent-activated cell sorting (FACS); Parkinson's disease (PD); patient-derived iPS; single-cell clones; isogenic cell lines; SNCA; alpha-synuclein; A30P
Online: 2 May 2020 (11:20:20 CEST)
ARTICLE
|
doi:10.20944/preprints202307.0476.v1
Subject:
Biology And Life Sciences,
Immunology And Microbiology
Keywords:
QIAGEN Knowledge Base (QKB); Ingenuity Pathway Analysis (IPA); Network Meta-analysis (NMA); Parkinson’s disease (PD); severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2); Coronavirus Disease-2019 (COVID-19); Neuroinflammation; Synuclein Alpha (SNCA); Angiotensin-converting enzyme-2 (ACE2)
Online: 7 July 2023 (10:55:52 CEST)